13F-HR/A filed by Redmile Group, LLC
Redmile Group, LLC filed this 13F-HR/A for the quarter ended 2018-09-30, filed 2019-05-16, with 83 holding rows worth $3,250,425,000.
- Accession
- 0001425738-19-000003
- Filer
- CIK 1425738
- Filed
- 2019-05-16
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2018
A holdings report, amendment of type restatement, 83 entries on the cover page, a total value of $3,250,425,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $3,250,425,000 with VALUE read as thousands by filing date, 13F file number 028-12776. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ARRAY BIOPHARMA INC COM | 04269X105 | Stock | 15,906,680 | $241,782,000 | thousands by filing date | |
| ATARA BIOTHERAPEUTICS INC COM NEW | 046513107 | Stock | 4,218,717 | $174,444,000 | thousands by filing date | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 10,359,666 | $168,759,000 | thousands by filing date | |
| REGENXBIO INC | 75901B107 | COM | 1,656,065 | $125,033,000 | thousands by filing date | |
| XENCOR INC | 98401F105 | COMMON STOCK | 3,030,143 | $118,085,000 | thousands by filing date | |
| IMMUNOGEN INC | 45253H101 | COMMON STOCK | 12,309,035 | $116,567,000 | thousands by filing date | |
| WAVE LIFE SCIENCES LTD SHS | Y95308105 | Stock | 2,273,307 | $113,665,000 | thousands by filing date | |
| ALDER BIOPHARMACEUTICALS INC | 014339105 | COM | 6,505,766 | $108,321,000 | thousands by filing date | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 8,402,617 | $101,588,000 | thousands by filing date | |
| AUDENTES THERAPEUTICS INC. | 05070R104 | Common Stock | 2,243,356 | $88,814,000 | thousands by filing date | |
| CIGNA CORPORATION | 125509109 | COM | 370,200 | $77,094,000 | thousands by filing date | |
| LIVANOVA PLC | G5509L101 | SHS | 599,288 | $74,294,000 | thousands by filing date | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 974,506 | $73,907,000 | thousands by filing date | |
| Inflarx Nv | N44821101 | COM | 2,024,900 | $69,495,000 | thousands by filing date | |
| ALLAKOS INC | 01671P100 | COM | 1,459,892 | $65,681,000 | thousands by filing date | |
| Elevance Health, Inc. | 036752103 | COM | 234,000 | $64,128,000 | thousands by filing date | |
| WRIGHT MED GROUP N V | N96617118 | ORD SHS | 2,173,700 | $63,081,000 | thousands by filing date | |
| ANAPTYSBIO INC | 032724106 | COM | 630,250 | $62,880,000 | thousands by filing date | |
| UNIQURE NV | N90064101 | SHS | 1,639,900 | $59,676,000 | thousands by filing date | |
| DECIPHERA PHARMACEUTICALS IN | 24344T101 | COM | 1,476,580 | $57,173,000 | thousands by filing date | |
| CLOVIS ONCOLOGY INC | 189464100 | COM | 1,778,300 | $52,229,000 | thousands by filing date | |
| ICU MED INC | 44930G107 | COM | 181,972 | $51,453,000 | thousands by filing date | |
| WELLCARE HEALTH PLANS INC | 94946T106 | COM | 155,909 | $49,967,000 | thousands by filing date | |
| TANDEM DIABETES CARE INC | 875372203 | COM NEW | 1,069,670 | $45,825,000 | thousands by filing date | |
| SCHOLAR ROCK HLDG CORP | 80706P103 | COM | 1,773,107 | $45,658,000 | thousands by filing date | |
| NIGHTSTAR THERAPEUTICS PLC | 65413A101 | ADR | 2,080,846 | $42,512,000 | thousands by filing date | |
| XERIS PHARMACEUTICALS INC | 98422L107 | COM | 2,412,640 | $42,414,000 | thousands by filing date | |
| EHEALTH INC | 28238P109 | COM | 1,472,595 | $41,616,000 | thousands by filing date | |
| HESKA CORP | 42805E306 | COM | 361,676 | $40,982,000 | thousands by filing date | |
| UnitedHealth Group Inc | 91324P102 | COM | 145,820 | $38,794,000 | thousands by filing date | |
| BLUEBIRD BIO INC | 09609G100 | COM | 252,100 | $36,807,000 | thousands by filing date | |
| OXFORD IMMUNOTEC GLOBAL PLC | G6855A103 | ORD SHS | 2,235,407 | $36,281,000 | thousands by filing date | |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 2,192,957 | $35,307,000 | thousands by filing date | |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 2,993,565 | $33,169,000 | thousands by filing date | |
| PENUMBRA INC COM | 70975L107 | Stock | 217,129 | $32,504,000 | thousands by filing date | |
| CENTENE CORP DEL COM | 15135B101 | Stock | 221,745 | $32,104,000 | thousands by filing date | |
| GRITSTONE BIO INC | 39868T105 | COM | 2,242,636 | $31,935,000 | thousands by filing date | |
| NUVASIVE INC | 670704105 | COM | 439,700 | $31,210,000 | thousands by filing date | |
| CVS Health Corporation | 126650100 | COM | 394,300 | $31,039,000 | thousands by filing date | |
| CATALENT INC USD 0.01 | 148806102 | COM | 668,850 | $30,466,000 | thousands by filing date | |
| GLYCOMIMETICS INC | 38000Q102 | COM | 2,048,147 | $29,493,000 | thousands by filing date | |
| TELADOC HEALTH INC | 87918A105 | COM | 334,700 | $28,901,000 | thousands by filing date | |
| PROQR THERAPEUTICS NV | N71542109 | SHS EURO | 1,450,925 | $28,075,000 | thousands by filing date | |
| ALDER BIOPHARMACEUTICALS INC | 014339AA3 | NOTE 2.500% 2/0 | 25,000,000 | $26,985,000 | thousands by filing date | principal |
| MORPHOSYS AG | 617760202 | ADR | 899,900 | $24,027,000 | thousands by filing date | |
| EPIZYME INC | 29428V104 | COM | 2,248,189 | $23,831,000 | thousands by filing date | |
| ARRAY BIOPHARMA INC | 04269XAB1 | NOTE 2.625%12/0 | 19,000,000 | $23,717,000 | thousands by filing date | principal |
| ZOETIS INC CL A | 98978V103 | Stock | 253,300 | $23,192,000 | thousands by filing date | |
| LHC GROUP | 50187A107 | COM | 217,480 | $22,398,000 | thousands by filing date | |
| SYNEOS HEALTH INC | 87166B102 | CL A | 428,473 | $22,088,000 | thousands by filing date | |
| PRA HEALTH SCIENCES INC | 69354M108 | COM | 200,000 | $22,038,000 | thousands by filing date | |
| AGILENT TECHNOLOGIES INC COM | 00846U101 | Stock | 306,400 | $21,613,000 | thousands by filing date | |
| SYROS PHARMACEUTICALS INC | 87184Q107 | COM | 1,656,138 | $19,725,000 | thousands by filing date | |
| ELANCO ANIMAL HEALTH INC COM | 28414H103 | Stock | 525,000 | $18,317,000 | thousands by filing date | |
| TRICIDA INC | 89610F101 | COM | 495,000 | $15,122,000 | thousands by filing date | |
| CHIMERIX INC COM | 16934W106 | Stock | 3,591,050 | $13,969,000 | thousands by filing date | |
| ODONATE THERAPEUTICS INC | 676079106 | COM | 605,300 | $11,749,000 | thousands by filing date | |
| SURGERY PARTNERS INC | 86881A100 | COM | 634,400 | $10,468,000 | thousands by filing date | |
| INVITAE CORP | 46185L103 | COM | 525,375 | $8,790,000 | thousands by filing date | |
| EIDOS THERAPEUTICS INC. | 28249H104 | Common Stock | 867,700 | $8,660,000 | thousands by filing date | |
| INTRICON CORP | 46121H109 | COM | 125,000 | $7,025,000 | thousands by filing date | |
| BEONE MEDICINES LTD SPONSORED ADS | 07725L102 | ADR | 40,300 | $6,940,000 | thousands by filing date | |
| NEURONETICS INC | 64131A105 | COM | 180,999 | $5,803,000 | thousands by filing date | |
| OVID THERAPEUTICS INC | 690469101 | COMMON STOCK | 730,150 | $4,140,000 | thousands by filing date | |
| ESTABLISHMENT LABS HOLDINGS | G31249108 | COMMON STOCK | 150,000 | $3,615,000 | thousands by filing date | |
| JOUNCE THERAPEUTICS INC | 481116101 | COM | 425,415 | $2,765,000 | thousands by filing date | |
| ARVINAS INC | 04335A105 | COM | 136,300 | $2,299,000 | thousands by filing date | |
| ENDOLOGIX INC | 29266S106 | COM | 810,461 | $1,548,000 | thousands by filing date | |
| RA MED SYS INC | 74933X104 | COM | 85,000 | $1,547,000 | thousands by filing date | |
| REPLIGEN CORP COM | 759916109 | Stock | 20,000 | $1,109,000 | thousands by filing date | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 30,000 | $523,000 | thousands by filing date | |
| MYOKARDIA INC | 62857M105 | COM | 7,170 | $467,000 | thousands by filing date | |
| ISHARES TR | 464288828 | US HLTHCR PR ETF | 2,087 | $417,000 | thousands by filing date | |
| HERON THERAPEUTICS INC | 427746102 | COM | 10,850 | $343,000 | thousands by filing date | |
| AMEDISYS INC | 023436108 | COM | 2,725 | $341,000 | thousands by filing date | |
| SAGE THERAPEUTICS INC | 78667J108 | COM | 2,170 | $307,000 | thousands by filing date | |
| VERICEL CORP | 92346J108 | COM | 20,000 | $283,000 | thousands by filing date | |
| JAZZ PHARMACEUTICALS PLC SHS USD | G50871105 | Stock | 1,590 | $267,000 | thousands by filing date | |
| FLEXION THERAPEUTICS INC | 33938J106 | COM | 13,260 | $248,000 | thousands by filing date | |
| SENSEONICS HLDGS INC | 81727U105 | COM | 44,900 | $214,000 | thousands by filing date | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 11,320 | $164,000 | thousands by filing date | |
| Adverum Biotechnologies, Inc. | 00773U108 | Common Stock | 22,236 | $135,000 | thousands by filing date | |
| CASTLIGHT HEALTH INC CL B | 14862Q100 | Stock | 10,229 | $28,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001425738-18-000027 | superseded | 2018-11-14 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001425738-19-000003 | this filing | 2019-05-16 | acceptance time not in the bulk data set |